WASHINGTON - University of Illinois researchers have observed that an FDA-approved drug, which is currently in use for diabetes treatment, shows some protective effects in the brains of patients with relapsing remitting multiple sclerosis.
WASHINGTON - A 10-week study has thrown up evidence that consumption of fructose-sweetened, not glucose-sweetened beverages, can adversely affect both sensitivity to insulin and how the body handles fats, creating conditions that invite heart attacks and strokes.
The recent label of diabetes drug Actos has gone through a big change and is updated. The current Product Monograph for Actos contains the following new or updated information:
- Actos should not be used in patients with any stage of heart failure (Contraindications section)
- Actos is not approved for use with metformin and a sulfonylurea.
On the occasion of the diabetes awareness month, this November, Handicap International has found that people loose lower limbs in diabetes than even landmine. That is the French charitable organization that has been awarded a Nobel prize for its work with people left crippled and handicapped in Vietnam, Cambodia and other countries by landmines.
With more than 24 million diabetic Americans, USA is on the verge of seeing a diabetes epidemic soon. Sedentary lifestyle, eating disorder, less physical activity are the main contributing reasons. However, a good and healthy lifestyle can be helpful to live a balanced life.
Diabetic retinopathy is a very common but serious eye related complication. Though it can effect any diabetic patient easily, but almost all person with type 1 diabetes show some symptoms of diabetic retinopathy usually after about 20 years of living with diabetes.
Report shows that in sample population (75.1 million) for which the incidence of type 1 diabetes is estimated covers 4.5% of the world’s population. In this type 1 diabetic population approximately 30,000 are Americans and near about 50% are children.